A CONTROLLED TRIAL OF INTRAVENOUS IMMUNE GLOBULIN FOR THE PREVENTION OF SERIOUS BACTERIAL INFECTIONS IN CHILDREN RECEIVING ZIDOVUDINE FOR ADVANCED HUMAN IMMUNODEFICIENCY VIRUS INFECTION

PEDIATRICS ◽  
1995 ◽  
Vol 96 (2) ◽  
pp. 408-408
Author(s):  
David Fuentes ◽  
William T. Shearer
Keyword(s):  
Human Immunodeficiency Virus ◽  
Virus Infection ◽  
Human Immunodeficiency Virus Infection ◽  
Bacterial Infection ◽  
Immune Globulin ◽  
Bacterial Infections ◽  
Controlled Trial ◽  
Immunodeficiency Virus ◽  
Aids Related Complex ◽  
Serious Bacterial Infections

Children with AIDS or AIDS-related complex receiving zidovudine have a decreased risk of bacterial infection when given IVIG. In this study, the benefit is most apparent in those not receiving trimethoprim- sulfamethoxazole prophylaxis.

Sign in / Sign up

Export Citation Format

Share Document